Table 2.
Variations in the perceived efficacy of providing buprenorphine between DATA-waivered providers and non-waivered providers
| Perceived efficacya | Waivered | Non-waivered | Mann–Whitney | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Disagree n (%) |
Neither n (%) |
Agree n (%) |
Mdn | Disagree n (%) |
Neither n (%) |
Agree n (%) |
Mdn | r | U | Pb | |
| Decreases risk of death from an opioid overdose | 1 (1) | 3 (3) | 101 (96) | 3 | 6 (8) | 16 (20) | 56 (72) | 3 | 0.34 | 5095 | < 0.001 |
| Decreases cravings for opioids | 1 (1) | 4 (4) | 101 (95) | 3 | 3 (4) | 10 (13) | 63 (83) | 3 | 0.20 | 4528 | 0.01 |
| Decreases rates of relapse | 2 (2) | 9 (8) | 95 (90) | 3 | 4 (5) | 17 (24) | 51 (71) | 3 | 0.24 | 4534 | < 0.001 |
| Works well in clients with co-occurring mental health disorders | 2 (2) | 9 (8) | 96 (90) | 3 | 3 (4) | 23 (32) | 47 (64) | 3 | 0.30 | 4886 | < 0.001 |
| Should be supplemented by mental health counseling | 4 (4) | 7 (7) | 88 (89) | 3 | 1 (1) | 6 (8) | 67 (91) | 3 | 0.03 | 3594 | 0.69 |
| Should be supplemented by participation in peer support groups | 3 (3) | 10 (9) | 93 (88) | 3 | 2 (3) | 8 (11) | 63 (86) | 3 | 0.02 | 3923 | 0.79 |
| Efficacy is improved by adding mental health counseling | 2 (2) | 8 (7) | 96 (91) | 3 | 0 | 6 (8) | 70 (92) | 3 | 0.03 | 3960 | 0.69 |
| Appropriate for unstable patients | 22 (21) | 32 (31) | 50 (48) | 2 | 24 (35) | 26 (38) | 18 (27) | 2 | 0.22 | 4398 | 0.004 |
Mdn median
aTotals vary due to missing values
bBold values indicate significance at an alpha of 0.05